Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.

Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.

Gastroenterology. 2009 Oct;137(4):1280-8.e1-6. doi: 10.1053/j.gastro.2009.06.059. Epub 2009 Jul 29.

PMID:
19596013
2.

Acute hepatitis C: current status and remaining challenges.

Santantonio T, Wiegand J, Gerlach JT.

J Hepatol. 2008 Oct;49(4):625-33. doi: 10.1016/j.jhep.2008.07.005. Epub 2008 Jul 17. Review.

3.

Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation.

Müllhaupt B, Dimitroulis D, Gerlach JT, Clavien PA.

J Hepatol. 2008;48 Suppl 1:S58-67. doi: 10.1016/j.jhep.2008.01.013. Epub 2008 Feb 4. Review.

4.

Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.

Lucas M, Ulsenheimer A, Pfafferot K, Heeg MH, Gaudieri S, Grüner N, Rauch A, Gerlach JT, Jung MC, Zachoval R, Pape GR, Schraut W, Santantonio T, Nitschko H, Obermeier M, Phillips R, Scriba TJ, Semmo N, Day C, Weber JN, Fidler S, Thimme R, Haberstroh A, Baumert TF, Klenerman P, Diepolder HM.

PLoS One. 2007 Jul 25;2(7):e649.

5.

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM.

J Virol. 2005 Oct;79(19):12425-33.

6.

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.

Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S330-5. Review.

PMID:
15768343
7.

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection.

Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wächtler M, Backmund M, Santantonio T, Schraut W, Heeg MH, Schirren CA, Zachoval R, Pape GR, Diepolder HM.

Hepatology. 2005 Mar;41(3):643-51.

PMID:
15726647
8.

Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation.

Gruener NH, Jung MC, Ulsenheimer A, Gerlach JT, Zachoval R, Diepolder HM, Baretton G, Schauer R, Pape GR, Schirren CA.

Liver Transpl. 2004 Dec;10(12):1487-96.

9.

Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.

Steinmann D, Barth H, Gissler B, Schürmann P, Adah MI, Gerlach JT, Pape GR, Depla E, Jacobs D, Maertens G, Patel AH, Inchauspé G, Liang TJ, Blum HE, Baumert TF.

J Virol. 2004 Sep;78(17):9030-40.

10.

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination.

Schirren CA, Zachoval R, Gerlach JT, Ulsenheimer A, Gruener NH, Diepolder HM, Baretton G, Schraut W, Rau HG, Nitschko H, Pape GR, Jung MC.

J Hepatol. 2003 Sep;39(3):397-404.

PMID:
12927926
11.

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR.

Gastroenterology. 2003 Jul;125(1):80-8.

PMID:
12851873
12.

Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C.

Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM.

Hepatology. 2003 May;37(5):1189-98.

PMID:
12717401
13.
14.

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.

Schirren CA, Jung MC, Worzfeld T, Mamin M, Baretton G, Gerlach JT, Gruener NH, Zachoval R, Houghton M, Rau HG, Pape GR.

J Infect Dis. 2001 Apr 15;183(8):1187-94. Epub 2001 Mar 14.

PMID:
11262200
15.

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.

Schirren CA, Jung MC, Gerlach JT, Worzfeld T, Baretton G, Mamin M, Hubert Gruener N, Houghton M, Pape GR.

Hepatology. 2000 Sep;32(3):597-603.

PMID:
10960455
16.

Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.

Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.

Liver Transpl. 2000 Mar;6(2):222-8.

PMID:
10719024
17.

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T, Pape GR.

Gastroenterology. 1999 Oct;117(4):933-41.

PMID:
10500077
18.

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.

Jung MC, Hartmann B, Gerlach JT, Diepolder H, Gruber R, Schraut W, Grüner N, Zachoval R, Hoffmann R, Santantonio T, Wächtler M, Pape GR.

Virology. 1999 Sep 1;261(2):165-72.

19.

Differential antigen-processing pathways of the hepatitis B virus e and core proteins.

Diepolder HM, Ries G, Jung MC, Schlicht HJ, Gerlach JT, Gr ner N, Caselmann WH, Pape GR.

Gastroenterology. 1999 Mar;116(3):650-7.

PMID:
10029624
20.

Determination of Hepatitis C Virus-Specific CD4(+) T-Cell Activity in PBMC.

Gerlach JT, Diepolder H, Pape GR.

Methods Mol Med. 1999;19:413-22. doi: 10.1385/0-89603-521-2:413.

PMID:
21374382
21.

A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.

Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Grüner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S, Pape GR.

Clin Exp Immunol. 1998 Aug;113(2):244-51.

22.

Immunopathogenesis of HCV infection.

Diepolder HM, Hoffmann RM, Gerlach JT, Zachoval R, Jung MC, Pape GR.

Curr Stud Hematol Blood Transfus. 1998;(62):135-51. Review. No abstract available.

PMID:
9507808
23.

Cell size of alveolar macrophages: an interspecies comparison.

Krombach F, Münzing S, Allmeling AM, Gerlach JT, Behr J, Dörger M.

Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3.

24.

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, Scholz S, Santantonio T, Houghton M, Southwood S, Sette A, Pape GR.

J Virol. 1997 Aug;71(8):6011-9.

25.

[46-year-old patient with recurrent hematemesis].

Gülberg V, Waggershauser T, Beuers U, Gerlach JT, Gerbes AL.

Internist (Berl). 1996 May;37(5):515-7. German. No abstract available.

PMID:
9011551
26.

Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease.

Krombach F, Gerlach JT, Padovan C, Burges A, Behr J, Beinert T, Vogelmeier C.

Eur Respir J. 1996 May;9(5):984-91.

27.

Immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid. Comparison of flow cytometric and immunocytochemical techniques.

Padovan CS, Behr J, Allmeling AM, Gerlach JT, Vogelmeier C, Krombach FP.

J Immunol Methods. 1992 Feb 14;147(1):27-32.

PMID:
1541839

Supplemental Content

Loading ...
Support Center